AMN Healthcare Services (AMN – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on May 9. Analyst Jeffrey Silber from BMO Capital maintained a Buy rating on the stock and has a $27.00 price target.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jeffrey Silber’s rating is based on several positive indicators for AMN Healthcare Services. The company delivered a strong performance by surpassing market expectations, particularly through improved margins and better-than-expected labor disruption revenues. Despite a year-over-year decline in revenues, the results were better than the guidance, indicating resilience in their core operations.
Furthermore, the company’s guidance for the second quarter of 2025 was optimistic, with expectations for both revenue and adjusted EBITDA exceeding consensus estimates. AMN’s management highlighted improvements in their pipeline and noted significant growth in Locums bookings, suggesting potential for future growth. The company is also positioned well in the healthcare staffing market, and while facing some challenges, it appears to be navigating them effectively, leading Silber to maintain a Buy rating.
According to TipRanks, Silber is a 5-star analyst with an average return of 9.4% and a 59.88% success rate. Silber covers the Industrials sector, focusing on stocks such as Trueblue, ManpowerGroup, and First Advantage.